E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/1/2005 in the Prospect News Biotech Daily.

Biotechnology Calendar

July 13-14

PULMONARY-ALLERGY DRUGS ADVISORY COMMITTEE (FDA)

Implications of recent data on safety of long-acting beta-agonist bronchodilators; need for the essential use designations of prescription drugs for the treatment of asthma and chronic obstructive pulmonary disease under 21 CFR 2.125

July 13-15

FOOD ADVISORY COMMITTEE (FDA)

Evaluate the Center for Food Safety and Applied Nutrition Threshold Working Group draft report "Approaches to Establish Thresholds for Major Food Allergens and Gluten; draft report's approaches for gluten thresholds; determination if report is scientifically sound in its analyses and approaches based on charge and questions from FDA

Sept. 12-14

PDA/FDA JOINT REGULATORY CONFERENCE - THE PRODUCT LIFE CYCLE: QUALITY BY DESIGN, IMPLEMENTATION AND CONTINUOUS IMPROVEMENT

Collaboration, education and networking between FDA, pharmaceutical and biopharmaceutical industries

Sept. 21-23

2005 BIO MID-AMERICA VENTUREFORUM

Showcase of biotech and medical device product and platform companies


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.